Diseases - Cytogenetic abnormalities, Markers, and Other unique features Flashcards
JAK2 kinase mutation
PV (100%)
MF (50%)
ET (50%)
t(9,22)
CML
B-ALL
-5q, -7q, +8
MDS
t(15;17)
APL (AML)
t(15;17), t(8;21), del(16)
11q23
AML: good prognosis
AML: bad prognosis
Langherhans cell histiocytosis
CD1, langherin, BRAF
markedly increased ferritin
HLH
Reactive T-lymphocytes, polylconal
Inflammatory mononucleosis
TdT
ALL (T and B)
TdT with t(13;21) or hyperdiploidy
TdT with t(9;22), hypodipoloidy, or 11q23
ALL - good prognosis
ALL - bad prognosis
CD5/19/23
CLL/SLL
CLL/SLL ctyogenetics, name:
Good prognosis
Intermediate prognosis
Bad prognosis
13q, IGHV(+)
+12
11q, 17p, IGHV(-)
TRAP, CD11a, CD22
Hairy cell leukemia
CD4, CD25, HTLV-1
ATLL
CD4, cerebriform nuclei
MF/SS
CD8, eosinophilic granules
LGLL
Mnemonic for end organ damage in MM
CRAB
hyperCalcemia
Renal damage
Anemia
Bone disease
Highly localized Plasma cell neoplasm, may be associated with MM
Plasmacytoma
IgM
LPL
Like MM, but with no end-organ damage
MGUS
CD10/19/20
Follicular lymphoma
Burkitt lymphoma
CD19/20
MALToma (extranodal)
DLBCL
T-helper cells, usually observed in adults, aggressive
Peripheral TCL
CTLs, ALK rearrangements, seen primarily in children, aggressive
Anaplastic LCL